Axsome Therapeutics Inc (AXSM)

[chainma1l]

Axsome currently does not anticipate future equity financings prior to the readout from its Phase 3 trials.

Because they know that the stock price is going to be much higher after these phase 3 results are announced. They'll get 3/4/5 times the money for 1/10th the shares. Based on that statement, it seems they may need money to get them through commercialization, but that could also come from a partner just as easily as selling a little stock.